Pirtobrutinib plus venetoclax rituximab improves PFS in previously treated CLL and SLL

Selinexor plus ruxolitinib improves spleen response and survival in Janus kinase inhibitor naïve myelofibrosis

Fatigue in adult ITP is common despite adequate platelet counts and minimal bleeding

Surovatamig plus rituximab induces high complete response rates in previously untreated follicular lymphoma

Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in acute ITP in 1L treatment during COVID 19

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Risk model predicts relapse after frontline blinatumomab in paediatric B-ALL

Epcoritamab induces deep and durable responses in chemotherapy-ineligible elderly patients with diffuse large B-cell lymphoma

Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell lymphomas

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy